Todd Asset Management LLC Cuts Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Todd Asset Management LLC reduced its stake in HCA Healthcare by 8.3% during the first quarter, owning approximately $43.37 million worth of shares after selling 11,419 shares.
• HCA Healthcare reported $6.84 EPS for the last quarter, exceeding consensus estimates, with a net revenue of $18.61 billion, a 6.4% increase year-over-year.
• The company announced a quarterly dividend of $0.72 per share, set to be paid on September 30th, representing an annualized yield of 0.8%.

Todd Asset Management LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 125,498 shares of the company's stock after selling 11,419 shares during the period. Todd Asset Management LLC owned 0.05% of HCA Healthcare worth $43,366,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Cheviot Value Management LLC purchased a new position in HCA Healthcare in the 1st quarter worth $26,000. Atwood & Palmer Inc. bought a new stake in HCA Healthcare during the first quarter worth about $28,000. Bartlett & CO. Wealth Management LLC lifted its stake in shares of HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares in the last quarter. ORG Partners LLC lifted its stake in shares of HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. raised its holdings in shares of HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.0%

Shares of HCA Healthcare stock traded up $0.03 during trading on Wednesday, hitting $390.34. The stock had a trading volume of 1,416,060 shares, compared to its average volume of 1,586,285. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The firm's fifty day simple moving average is $370.06 and its 200-day simple moving average is $350.57. The stock has a market cap of $91.34 billion, a PE ratio of 16.41, a PEG ratio of 1.23 and a beta of 1.39. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the business posted $5.50 EPS. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Barclays reduced their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Royal Bank Of Canada cut their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $395.69.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.